What is Achieve Life Sciences's indemnification expense?

Achieve Life Sciences (ACHV) reported indemnification expense of $0 in Q1 2026.

What does indemnification expense mean?

This metric captures the costs incurred by the company to compensate or protect third parties against losses or damages arising from specific legal or contractual obligations. It reflects potential liabilities related to litigation, regulatory compliance, or contractual breaches. High or recurring expenses in this category may signal significant legal or operational risk exposure.

Achieve Life Sciences ACHV Indemnification Expense

Indemnification Expense at other companies

Resideo Technologies, Inc.REZI

$0-100%

PrecigenPGEN

-$184.25K+60.4%

KadantKAI

$0-100%

Neuropace, Inc.NPCE

$0—

Varonis SystemsVRNS

$0-100%

Capital SouthwestCSWC

$6.4M—

Other financials

Income statement

See full

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Balance sheet

See full

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Cash flow

See full

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Valuation

See full

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Returns & leverage

See full

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept achv:IndemnificationExpense.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's indemnification expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Achieve Life Sciences's indemnification expense?: Achieve Life Sciences (ACHV) reported indemnification expense of $0 in Q1 2026.
What does indemnification expense mean?: This metric captures the costs incurred by the company to compensate or protect third parties against losses or damages arising from specific legal or contractual obligations. It reflects potential liabilities related to litigation, regulatory compliance, or contractual breaches. High or recurring expenses in this category may signal significant legal or operational risk exposure.